Inpharma Weekly

, Volume 1644, Issue 1, pp 11–11 | Cite as

Ecallantide: final HAE patient treated in the second phase III trial

Media release


Clinical Trial Medium Release Acute Attack Angioedema Threatening Condition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations